Table 1.
Patient | Age (years) at |
Cause of central hypo | Body weight (kg) | Daily dose (μg/kg bw) of tablet l-T4 |
||
---|---|---|---|---|---|---|
Our observation | Diagnosis of central hypo | Initial | Finala | |||
1, F | 48 | 46 | Head trauma | 83 | 1.21 | 1.51 |
2, F | 57 | 50 | Pituitary microadenoma | 64 | 1.18 | 1.41 |
3, F | 59 | 53 | Empty sella | 76 | 1.32 | 1.65 |
4, F | 42 | 39 | Pituitary microadenoma | 60 | 1.50 | 1.67 |
5, M | 20 | 16 | Empty sella | 55 | 1.18 | 1.29 |
6, M | 45 | 44 | Head trauma | 82 | 1.22 | 1.22 |
7, M | 74 | 69 | Empty sella | 70 | 1.43 | 1.83 |
aSwitch to the novel formulations of l-T4 was done at the indicated final dose.